China Viral-Vectored Vaccines Market Research Report Forecast 2017-2021

March 2017 | 133 pages | ID: CBE0DBA62E0EN
S&P Consulting

Abstracts

The China Viral-Vectored Vaccines Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Viral-Vectored Vaccines industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Viral-Vectored Vaccines market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
Bayer HealthCare AG (Germany)
Biogenesis-Bago (Argentina)
Boehringer Ingelheim GmbH (Germany)
Ceva Sante Animale (France)
Heska Corporation (US)

• Indian Immunologicals Ltd (India)

Lohmann Animal Health (US)
Merck Animal Health (US)
Merial Ltd. (US)
China Viral-Vectored Vaccines Market: Product Segment Analysis

• Type 1
• Type 2
• Type 3

China Viral-Vectored Vaccines Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

REASONS FOR BUYING THIS REPORT

This report provides pin-point analysis for changing competitive dynamics

• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 VIRAL-VECTORED VACCINES MARKET OVERVIEW

1.1 Product Overview and Scope of Viral-Vectored Vaccines
1.2 Viral-Vectored Vaccines Market Segmentation by Type
  1.2.1 China Production Market Share of Viral-Vectored Vaccines by Type 1n 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Viral-Vectored Vaccines Market Segmentation by Application
  1.3.1 Viral-Vectored Vaccines Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Viral-Vectored Vaccines (2012-2021)

CHAPTER 2 CHINA ECONOMIC IMPACT ON VIRAL-VECTORED VACCINES INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Viral-Vectored Vaccines Industry

CHAPTER 3 CHINA VIRAL-VECTORED VACCINES MARKET COMPETITION BY MANUFACTURERS

3.1 China Viral-Vectored Vaccines Production and Share by Manufacturers (2015 and 2016)
3.2 China Viral-Vectored Vaccines Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Viral-Vectored Vaccines Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Viral-Vectored Vaccines Manufacturing Base Distribution, Production Area and Product Type
3.5 Viral-Vectored Vaccines Market Competitive Situation and Trends
  3.5.1 Viral-Vectored Vaccines Market Concentration Rate
  3.5.2 Viral-Vectored Vaccines Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA VIRAL-VECTORED VACCINES CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China Viral-Vectored Vaccines Capacity, Production and Growth (2012-2017)
4.2 China Viral-Vectored Vaccines Revenue and Growth (2012-2017)
4.3 China Viral-Vectored Vaccines Production, Consumption, Export and Import (2012-2017)

CHAPTER 5 CHINA VIRAL-VECTORED VACCINES PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Viral-Vectored Vaccines Production and Market Share by Type (2012-2017)
5.2 China Viral-Vectored Vaccines Revenue and Market Share by Type (2012-2017)
5.3 China Viral-Vectored Vaccines Price by Type (2012-2017)
5.4 China Viral-Vectored Vaccines Production Growth by Type (2012-2017)

CHAPTER 6 CHINA VIRAL-VECTORED VACCINES MARKET ANALYSIS BY APPLICATION

6.1 China Viral-Vectored Vaccines Consumption and Market Share by Application (2012-2017)
6.2 China Viral-Vectored Vaccines Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA VIRAL-VECTORED VACCINES MANUFACTURERS ANALYSIS

7.1 Bayer HealthCare AG (Germany)
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Business Overview
7.2 Biogenesis-Bago (Argentina)
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Business Overview
7.3 Boehringer Ingelheim GmbH (Germany)
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Business Overview
7.4 Ceva Sante Animale (France)
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Business Overview
7.5 Heska Corporation (US)
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Business Overview
7.6 Indian Immunologicals Ltd (India)
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Business Overview
7.7 Lohmann Animal Health (US)
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Business Overview
7.8 Merck Animal Health (US)
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Business Overview
7.9 Merial Ltd. (US)
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Business Overview
…

CHAPTER 8 VIRAL-VECTORED VACCINES MANUFACTURING COST ANALYSIS

8.1 Viral-Vectored Vaccines Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Viral-Vectored Vaccines

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Viral-Vectored Vaccines Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Viral-Vectored Vaccines Major Manufacturers in 2015
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA VIRAL-VECTORED VACCINES MARKET FORECAST (2017-2021)

12.1 China Viral-Vectored Vaccines Production, Revenue Forecast (2017-2021)
12.2 China Viral-Vectored Vaccines Production, Consumption Forecast by Regions (2017-2021)
12.3 China Viral-Vectored Vaccines Production Forecast by Type (2017-2021)
12.4 China Viral-Vectored Vaccines Consumption Forecast by Application (2017-2021)
12.5 Viral-Vectored Vaccines Price Forecast (2017-2021)

CHAPTER 13 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Viral-Vectored Vaccines
Figure China Production Market Share of Viral-Vectored Vaccines by Type 1n 2016
Table Viral-Vectored Vaccines Consumption Market Share by Application in 2016
Figure China Viral-Vectored Vaccines Revenue (Million USD) and Growth Rate (2012-2021)
Table China Viral-Vectored Vaccines Capacity of Key Manufacturers (2015 and 2016)
Table China Viral-Vectored Vaccines Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Viral-Vectored Vaccines Capacity of Key Manufacturers in 2015
Figure China Viral-Vectored Vaccines Capacity of Key Manufacturers in 2016
Table China Viral-Vectored Vaccines Production of Key Manufacturers (2015 and 2016)
Table China Viral-Vectored Vaccines Production Share by Manufacturers (2015 and 2016)
Figure 2015 Viral-Vectored Vaccines Production Share by Manufacturers
Figure 2016 Viral-Vectored Vaccines Production Share by Manufacturers
Table China Viral-Vectored Vaccines Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Viral-Vectored Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Viral-Vectored Vaccines Revenue Share by Manufacturers
Table 2016 China Viral-Vectored Vaccines Revenue Share by Manufacturers
Table China Market Viral-Vectored Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Viral-Vectored Vaccines Average Price of Key Manufacturers in 2015
Table Manufacturers Viral-Vectored Vaccines Manufacturing Base Distribution and Sales Area
Table Manufacturers Viral-Vectored Vaccines Product Type
Figure Viral-Vectored Vaccines Market Share of Top 3 Manufacturers
Figure Viral-Vectored Vaccines Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Viral-Vectored Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Viral-Vectored Vaccines Market Share (2012-2017)
Table Bayer HealthCare AG (Germany) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Market Share (2012-2017)
Table Biogenesis-Bago (Argentina) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Market Share (2012-2017)
Table Boehringer Ingelheim GmbH (Germany) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Market Share (2012-2017)
Table Ceva Sante Animale (France) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Ceva Sante Animale (France) Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Ceva Sante Animale (France) Viral-Vectored Vaccines Market Share (2012-2017)
Table Heska Corporation (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Heska Corporation (US) Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Heska Corporation (US) Viral-Vectored Vaccines Market Share (2012-2017)
Table Indian Immunologicals Ltd (India) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Market Share (2012-2017)
Table Lohmann Animal Health (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Lohmann Animal Health (US) Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Lohmann Animal Health (US) Viral-Vectored Vaccines Market Share (2012-2017)
Table Merck Animal Health (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck Animal Health (US) Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Merck Animal Health (US) Viral-Vectored Vaccines Market Share (2012-2017)
Table Merial Ltd. (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merial Ltd. (US) Viral-Vectored Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Merial Ltd. (US) Viral-Vectored Vaccines Market Share (2012-2017)
Figure Production Revenue Share of Viral-Vectored Vaccines by Type (2012-2017)
Figure 2015 Revenue Market Share of Viral-Vectored Vaccines by Type
Table China Viral-Vectored Vaccines Price by Type (2012-2017)
Figure China Viral-Vectored Vaccines Production Growth by Type (2012-2017)
Table China Viral-Vectored Vaccines Consumption by Application (2012-2017)
Table China Viral-Vectored Vaccines Consumption Market Share by Application (2012-2017)
Figure China Viral-Vectored Vaccines Consumption Market Share by Application in 2015
Table China Viral-Vectored Vaccines Consumption Growth Rate by Application (2012-2017)
Figure China Viral-Vectored Vaccines Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Viral-Vectored Vaccines
Figure Manufacturing Process Analysis of Viral-Vectored Vaccines
Figure Viral-Vectored Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Viral-Vectored Vaccines Major Manufacturers in 2015
Table Major Buyers of Viral-Vectored Vaccines
Table Distributors/Traders List
Figure China Viral-Vectored Vaccines Capacity, Production and Growth Rate Forecast (2017-2021)
Figure China Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2017-2021)
Table China Viral-Vectored Vaccines Production, Import, Export and Consumption Forecast (2017-2021)
Table China Viral-Vectored Vaccines Production Forecast by Type (2017-2021)
Table China Viral-Vectored Vaccines Consumption Forecast by Application (2017-2021)